Delivering to Gurgaon
Hi, there!
Login / Sign Up
Buy medicines
Buy health products
Book lab tests
Consult a doctor
1mg Care Plan
Cancer Care
Ayurveda
Partnerships
New
Hindi articles
Offers
All diseases
New
All medicines
Medicines by therapeutic class
Contact us
Need help?
Privacy policy
Return policy
Terms and conditions
Editorial policy
Get more features! Download the app now
Medicine Reminders
Monthly/weekly subscriptions
Health records and analysis
24*7 Emergency services
Download app on the App StoreDownload app on the Google play store
Choose city
Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy

Molusafe 200mg Capsule

Written By Dr. Swati Mishra, BDS
Reviewed By Dr. Rajeev Sharma, MBA, MBBS
Last updated on 07 Nov 2024 | 01:05 AM (IST)
Molusafe 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.
Genuine
Authenticity Assured
Prescription
required
Welcome Gift
10% EXTRA OFF on first order
with1MGANEW| Cash on delivery available
₹640
Get for
₹576
right chevron icon
on orders above ₹150
Use Code 1MGANEW
Get for
₹589
right chevron icon
on orders above ₹200
Use Code 1MGANEW
1/2
10 capsules
 
 
0
footer-icon
efsr frrrrrr
aaa

General Information

Contains

Molnupiravir (200mg)

Marketer

Astraea Life Sciences Pvt Ltd
The content is shown in English
Molusafe 200mg Capsule image

Product introduction

Molusafe 200mg Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use.

Molusafe 200mg Capsule should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them.

Before taking Molusafe 200mg Capsule, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Molusafe 200mg Capsule is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.

Uses of Molusafe Capsule

  • Treatment of Mild to moderate Coronavirus disease (COVID-19)

Benefits of Molusafe Capsule

Treatment of Mild to moderate Coronavirus disease (COVID-19)
Molusafe 200mg Capsule helps manage mild to moderate Covid-19 symptoms in those individuals who are at a high risk of developing severe Covid-19 disease and do not need oxygen administration. This medicine may help you recover from the infection if diagnosed early before hospitalization. If you think you have come in contact with a person who has been infected with Covid-19, or if you feel any of these symptoms, consult your doctor immediately.

Side effects of Molusafe Capsule

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Molusafe
  • Nausea
  • Dizziness
  • Diarrhea

How to use Molusafe Capsule

Take this medicine in the dose and duration as advised by your doctor. Molusafe 200mg Capsule may be taken with or without food, but it is better to take it at a fixed time.

How Molusafe Capsule works

Molusafe 200mg Capsule is an antiviral medicine. It works by inhibiting the SARS-CoV-2 virus from replicating. This stops the virus from producing new copies and hence decreases the viral load in the body.

All substitutes for Molusafe 200mg Capsule

For information purposes only. Consult a doctor before taking any medicine.

Molunamax 200 Capsule

by J B Chemicals and Pharmaceuticals Ltd
₹65/capsule
2% costlier
<h3 class=bodySemiBold>Molunamax 200 Capsule</h3>

Molulow 200mg Capsule

by MSN Laboratories
₹64/capsule
same price
<h3 class=bodySemiBold>Molulow 200mg Capsule</h3>

Molena 200mg Capsule

by Emcure Pharmaceuticals Ltd
₹31.25/capsule
51% cheaper
<h3 class=bodySemiBold>Molena 200mg Capsule</h3>

Molnunat 200mg Capsule

by Natco Pharma Ltd
₹50/capsule
22% cheaper
<h3 class=bodySemiBold>Molnunat 200mg Capsule</h3>

Molnulup 200mg Capsule

by Lupin Ltd
₹26.67/capsule
58% cheaper
<h3 class=bodySemiBold>Molnulup 200mg Capsule</h3>

Quick tips

  • Do not give Molusafe 200mg Capsule to children and adolescents aged less than 18 years.
  • Do not stop taking Molusafe 200mg Capsule without talking to your doctor first, as it will protect you from becoming severely ill from COVID-19.
  • Even after the treatment, continue practicing COVID-appropriate behavior such as wearing a mask, social distancing, and frequent handwashing.
  • For individuals with conceiving potential, it is advisable to use contraceptive methods while taking Molnupiravir and for 4 days after the last dose of the medicine.

Safety advice

Alcohol

Alcohol

CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Molusafe 200mg Capsule. Please consult your doctor.
Pregnancy

Pregnancy

CONSULT YOUR DOCTOR
Molusafe 200mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding

Breast feeding

UNSAFE
Molusafe 200mg Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving

Driving

CONSULT YOUR DOCTOR
It is not known whether Molusafe 200mg Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney

Kidney

SAFE IF PRESCRIBED
Molusafe 200mg Capsule is safe to use in patients with kidney disease. No dose adjustment of Molusafe 200mg Capsule is recommended.
Liver

Liver

SAFE IF PRESCRIBED
Molusafe 200mg Capsule is safe to use in patients with liver disease. No dose adjustment of Molusafe 200mg Capsule is recommended.
sljrsr jrjrrrrr

Frequently asked questions

No, Molusafe 200mg Capsule is not approved for use in children or patients below the age of 18 years as it may interfere with the growth of bones and cartilage.
Molusafe 200mg Capsule has better patient compliance than some other treatment options available against COVID-19. Unlike other medicines that may need a skilled healthcare professional (a doctor or a nurse) to administer, Molusafe 200mg Capsule is an oral medicine that can be consumed by mouth in the dosage and schedule prescribed by the doctor.
Yes, there are some serious risks involved with using Molusafe 200mg Capsule, including its potential to cause birth defects in pregnant women and serious damage to the growth of bones and cartilage (which may cause serious muscle damage). Therefore, Molusafe 200mg Capsule should be used only if prescribed by a doctor and not used for self-medication.
No. There is no comparison between the two, and Molusafe 200mg Capsule is not a substitute for getting vaccinated. Vaccination is for prevention, while Molusafe 200mg Capsule is used to treat an existing COVID-19 infection, provided the infection is diagnosed at an early stage.
People who are at a high risk of developing severe COVID-19 include those aged above 60 years, who are obese, have comorbid conditions including high blood pressure, diabetes, asthma, other medical conditions related to the lungs, kidneys (like dialysis patients), liver, or those who have a weak immunity (like cancer patients).
Molusafe 200mg Capsule should not be taken to prevent COVID-19 or treat patients hospitalized due to COVID-19. According to the ongoing clinical trials, patients hospitalized with severe COVID-19 infection have not benefited from taking Molusafe 200mg Capsule.

Fact Box

Chemical Class

Cytosine Nucleotides

Habit Forming

No

Therapeutic Class

ANTI INFECTIVES

Action Class

Antiviral (Non-HIV) drugs

References

  1. Molnupiravir [EMC SmPC]. London, UK: Merck Sharp & Dohme (UK) Limited; 2021. [Accessed 05 Jan. 2022] (online) Available from:
  2. U.S. Food and Drug Administration: Center for Drug Evaluation and Research FDA Briefing Document, Antimicrobial Drugs Advisory Committee Meeting, November 30, 2021. [Accessed 05 Jan. 2022] (online) Available from:
  3. Cipla receives Emergency Use Authorisation (EUA) to launch oral anti-viral drug Cipmolnu®(Molnupiravir 200mg) in India for treatment of adult patients with COVID-19, with SpO2>93% and with high risk of disease progression including hospitalization or death. Cipla: Press Statement. [Accessed 05 Jan. 2022] (online) Available from:
  4. Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India. Sun Pharma: Press Release. [Accessed 05 Jan. 2022] (online) Available from:
  5. Molnupiravir. U.S. Food & Drug Administration Antimicrobial Drugs Advisory Committee November 30, 2021. [Accessed 05 Jan. 2022] (online) Available from:
  6. EUnetHTA Rolling Collaborative Review (RCR19) Authoring Team. Molnupiravir for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2020. Report No.: RCR19, v1.0. [Accessed 05 Jan. 2022] (online) Available from:
  7. Molnupiravir [Package leaflet: Information for the patient]. London, UK: Merck Sharp & Dohme (UK) Limited; 2021. [Accessed 05 Jan. 2022] (online) Available from:
  8. European Medicines Agency. Assessment Report: Use of molnupiravir for the treatment of COVID-19. [Accessed 05 Jan. 2022] (online) Available from:
  9. Kabinger F, Stiller C, Schmitzová J, et al. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol. 2021;28(9):740-746. [Accessed 05 Jan. 2022] (online) Available from:
  10. FDA News Release. Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults. December 23, 2021. [Accessed 6th Jan. 2022] (online) Available from:
test
100% genuine products
100% genuine products
Safe & secure payments
Safe & secure payments
No contact delivery
No contact delivery
Fully sanitized facilities
Fully sanitized facilities

Patient concerns

I got married 1 year ago we don't have a child yet what to do ?

Dr. Sonu Balhara Ahlawat
Dr. Sonu Balhara Ahlawat
Obstetrics and Gynaecology
Wait for sometime u are only 19

She has suffering from acute migraine for 3 to four days

Dr. Vikas Sharma
Dr. Vikas Sharma
Neurology
do mri brain; take naxdom 1 bd fro 3v days then sos; tryptomer 19 mg hs10 mg instead of 19 mg
<h3 class=titleMediumExtraBold>Want to know more</h3>

Want to know more

We provide you with authentic, trustworthy and relevant information
<h3 class=titleMediumExtraBold>Have issue with the content</h3>

Have issue with the content

Disclaimer

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Marketer details

Name: Astraea Life Sciences Pvt Ltd
Address: “Astraea Court” # 9/12,GF, 5th Cross, 10th Main Road,Sree Guru Raja Lay out, Banashankari-3rd Stage,Bangalore-560085

Vendor Details

Country of origin: India
A licensed vendor partner from your nearest location will deliver Molusafe 200mg Capsule. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.

In case of any issues, contact us

Email ID: [email protected]
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India

Lab tests offered by us

Why we need a prescription?
Image of Step
Provide right medicines
Prescriptions are complex documents. We proof read and recheck at various steps to provide you the right medication in the correct form and dose
Image of Step
In accordance with the law
Most medicines cannot be sold without a valid prescription, as per the Drugs and Cosmetics Act, 1940 and Rules, 1945
close sheet